6.95 USD
▼-0.02-2.80%
盘后 7.26 +1.54%
2026-08-03
市值
$7.28B
市盈率
—
EPS
-0.89
股息率
—
52 周区间
1.95 – 12.43
成交量
19.01M
Beta
0.08
目标价
12.75
52W 低 1.9552W 高 12.43
价格走势
公司简介
ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient’s immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company’s platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and so...